Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/4166 stock hub

TPEX/4166 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4166is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.8B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4166

In the news

Latest news · TPEX/4166

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E28.8

P25 14.4P50 18P75 31.9

ROE9.6

P25 -16.2P50 0.3P75 9.8

ROIC10.4

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4166 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

TWD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	173
Enterprise value	TWD 5.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0004166004
Last refreshed	2026-05-10
Market cap	TWD 5.8B
Price	TWD 26.05
Price currency	TWD
Rev Per Employee	8,094,670.52x
Sector	Healthcare
Sic	2834
Symbol	tpex/4166
Website	https://www.oppharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.59%
EV Earnings	25.8x
EV/EBIT	20.6x
EV/EBITDA	13.62x
EV/FCF	16.6x
EV/Sales	3.84x
FCF yield	5.58%
P/B ratio	2.27x
P/E ratio	28.8x
P/S ratio	4.15x
PE Ratio3 Y	77.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.64%
EBITDA Margin	26.81%
FCF margin	23.14%
Gross margin	56.46%
Gross Profit	TWD 790.7M
Gross Profit Growth	21.36%
Gross Profit Growth Q	51.7%
Gross Profit Growth3 Y	72.02%
Gross Profit Growth5 Y	60.11%
Net Income	TWD 208.4M
Net Income Growth	94.12%
Net Income Growth Q	706.86%
Net Income Growth Quarters	2%
Net Income Growth Years	6%
Pretax Margin	17.47%
Profit Margin	14.88%
Profit Per Employee	TWD 1.2M
Profitable Years	3
ROA	5.98
Roa5y	0.87
ROCE	9.49
ROE	9.58
Roe5y	1.2
ROIC	10.44
Roic5y	0.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.84%
Cagr1y	-13.32%
Cagr3y	5.32%
Cagr5y	10.59%
EPS Growth	87.89
EPS Growth Q	640.1
EPS Growth Quarters	2
EPS Growth Years	6
FCF Growth	92.45%
FCF Growth Q	108.24%
OCF Growth	83.87%
OCF Growth Q	75.04%
OCF Growth3 Y	216.19%
Revenue Growth	14.52x
Revenue Growth Q	38.4x
Revenue Growth Quarters	10x
Revenue Growth Years	6x
Revenue Growth3 Y	39.86x
Revenue Growth5 Y	27.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.51
Assets	TWD 2.9B
Cash	TWD 627.4M
Current Assets	TWD 1.3B
Current Liabilities	TWD 187.1M
Debt	TWD 195.9M
Debt EBITDA	TWD 0.5
Debt Equity	TWD 0.08
Debt FCF	TWD 0.6
Equity	TWD 2.6B
Interest Coverage	33.01
Liabilities	TWD 374.9M
Long Term Assets	TWD 1.7B
Long Term Liabilities	TWD 187.8M
Net Cash	TWD 431.4M
Net Cash By Market Cap	TWD 7.43
Net Debt EBITDA	TWD -1.15
Net Debt Equity	TWD -0.17
Net Debt FCF	TWD -1.33
Tangible Book Value	TWD 2.1B
Tangible Book Value Per Share	TWD 9.63
WACC	4.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.73
Inventory Turnover	2.03
Net Working Capital	TWD 460.8M
Quick ratio	4.77
Working Capital	TWD 1.1B
Working Capital Turnover	TWD 2.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-8.06%
1Y total return	-13.31%
200-day SMA	26.98
3Y total return	16.82%
50-day SMA	25.44
50-day SMA vs 200-day SMA	50under200
5Y total return	65.4%
All Time High	99.99
All Time High Change	-73.95%
All Time High Date	2013-10-30
All Time Low	12.5
All Time Low Change	108.4%
All Time Low Date	2020-03-23
ATR	0.85
Beta	0.12
Beta1y	0.44
Beta2y	0.28
Ch YTD	-0.38
High	26.6
High52	40
High52 Date	2025-06-10
High52ch	-34.88%
Low	26.05
Low52	22.3
Low52 Date	2025-09-02
Low52ch	16.82%
Ma50ch	2.4%
Price vs 200-day SMA	-3.46%
RSI	51.33
RSI Monthly	47.16
RSI Weekly	47.49
Sharpe ratio	-0.31x
Sortino ratio	-0.34
Total Return	-3.32%
Tr YTD	-0.38
Tr1m	2.16%
Tr1w	0.19%
Tr3m	-2.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 261.1M
Operating Income Growth	65.32
Operating Income Growth Q	219.3
Operating margin	18.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	37,167,312%
Net Borrowing	-350,538,000
Shares Insiders	1.03%
Shares Out	223,035,089
Shares Qo Q	4.64%
Shares Yo Y	3.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 323.6M
Average Volume	271,702.65x
Bv Per Share	11.49
CAPEX	TWD -35.8M
Ch10y	-15.07
Ch1m	2.16
Ch1w	0.19
Ch1y	-13.31
Ch3m	-2.07
Ch3y	16.82
Ch5y	65.4
Ch6m	6.11
Change	-0.95%
Change From Open	-2.07
Close	26.3
Days Gap	1.14
Depreciation Amortization	114,449,000
Dollar Volume	7,333,856.5
Earnings Date	2026-08-13
EBIT	TWD 261.1M
EBITDA	TWD 375.5M
EPS	TWD 0.9
F Score	7
FCF	TWD 324M
FCF EV Yield	6.02x
FCF Per Share	TWD 1.45
Financing CF	218,029,000
Fiscal Year End	December
Founded	2,008
Graham Number	15.29453
Graham Upside	-41.29
Income Tax	TWD 36.2M
Investing CF	-73,067,000
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-12-31
Last Split Date	2016-05-23
Last Split Type	Reverse
Ma150	25.69
Ma150ch	1.41%
Ma20	25.94
Ma20ch	0.43%
Net CF	503,103,000
Next Earnings Date	2026-08-13
Open	26.6
P FCF Ratio	17.93
P OCF Ratio	16.15
Position In Range	0
Ppne	835,575,000
Price Date	2026-05-08
Price EBITDA	TWD 15.47
Ptbv Ratio	2.7
Relative Volume	1.05x
Revenue	1,400,378,000x
SBC By Revenue	0.03x
Share Based Comp	484,000
Tax By Revenue	2.59x
Tax Rate	14.8%
Tr6m	6.11%
Volume	281,530
Z Score	12.26

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/4166 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4166 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4166?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.3%

Negative means the company is buying back shares.

Technical

TPEX/4166 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.3

Neutral momentum band

Price vs 200-day MA

-3.5%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

-0.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4166

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4166 stock rating?

tpex/4166 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4166 analysis?

The full report lives at /stocks/tpex/4166/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4166?

The latest report frames tpex/4166 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4166 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.